Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinder, officially known as Shandong Sinder Technology, is a prominent Chinese biotechnology company specializing in the animal health sector. Founded in 1999, the company focuses on the research, development, and manufacturing of veterinary vaccines, pharmaceuticals, and diagnostic reagents for livestock and poultry. Sinder is a leader in the application of advanced technologies such as reverse genetics and high-density cell culture to produce innovative vaccines for diseases like avian influenza and PRRS. The company operates multiple state-of-the-art R&D centers and manufacturing facilities that comply with international GMP standards. Sinder's products are critical for maintaining biosecurity in the global food supply chain, and the company maintains extensive collaborations with top-tier academic and research institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sinder.